Zusammenfassung
Nichtneoplastische, durch HPV bedingte Veränderungen an Vulva und Vagina sind häufig und teilweise mit einer kondylomatösen Läsion assoziiert. Die klassische Einteilung der Präkanzerosen der Vulva in vulväre intraepitheliale Neoplasien (VIN) 1–3 wird zunehmend durch die Definition einer klassischen und differenzierten VIN abgelöst. Die Einteilung der Präkanzerosen der Vagina (vaginale intrapepitheliale Neoplasie, VAIN) folgt dem Konzept wie bei der Cervix uteri. Zur Abgrenzung einer kondylomatösen Läsion gegenüber einer Präkanzerose ist der immunhistochemische p16-Nachweis hilfreich. HPV-assoziierte Karzinome der Vulva und Vagina sind das verruköse, das kondylomatöse („warty“) Karzinom und das (nicht)verhornende Plattenepithelkarzinom ohne besondere Differenzierung (NOS) sowie in der Vagina das sehr seltene squamotransitionelle Karzinom.
Abstract
Non-neoplastic HPV-induced alterations of the vulva and vagina are frequent. The traditional three-tier grading system of vulvar intraepithelial neoplasia (VIN) will be replaced by the definition of usual and simplex type of VIN. The usual type is characterized by a strong association to high-risk HPV infections, the occurrence at younger age and multifocality, mostly associated with non-keratinizing squamous cell carcinoma. The differentiated (or simplex) type is rare and shows an association to older age and p53 alterations and is typically diagnosed co-incidentally with keratinizing squamous cell carcinoma. Vaginal intraepithelial neoplasia (VAIN) is still graded into VAIN 1–3 where VAIN 1 and 2 are mostly associated with low-risk HPV infections and a high spontaneous regression rate whereas VAIN 3 represents a high-risk HPV-associated lesion with capable progression into (micro-)invasive carcinoma. The differential diagnosis between a non-neoplastic condylomatous lesion and VIN common type and VAIN may be aided by p16 immunohistochemistry. The HPV-associated invasive vulvo-vaginal cancers are verrucous carcinoma (low-risk HPV) and the high-risk HPV-induced (non-keratinizing) squamous cell carcinoma (NOS), the condylomatous (warty) carcinoma and the very rare vaginal squamo-transitional carcinoma.
Literatur
Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) (2009) Interdisziplinäre S 2 k-Leitlinie für die Diagnostik und Therapie des Vulvakarzinoms 2009. http://www.ago-online.de/leitlinien
Al-Ghamdi A, Freedman D, Miller D et al (2002) Vulvar squamous cell carcinoma in young women: a clinicopathologic study of 21 cases. Gynecol Oncol 84:94–101
Andersen ES, Paavonen J, Murnaghan M et al (2003) Tumors of the vagina. In: Tavassoli FA, Devilee P (Hrsg) Pathology and genetics of tumours of the breast and female genital organs. World Health Organization classification of tumours. IARC, Lyon, S 291–301
Beller U, Benedet JL, Creasman WT et al (2006) Carcinoma of the vagina. FIGO 6th annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet 95(Suppl 1):29–42
Bosch FX, Burchell AN, Schiffman M et al (2008) Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine 26(Suppl 10):K1–K16
Brown DR, Shew ML, Qadadri B et al (2005) A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women. J Infect Dis 191:182–192
Carlson JA, Ambros R, Malfetano J et al (1998) Vulvar lichen sclerosus and squamous cell carcinoma: a cohort, case control, and investigational study with historical perspective; implications for chronic inflammation and sclerosis in the development of neoplasia. Hum Pathol 29:932–948
Centers for Disease Control and Prevention( 2004) Genital HPV Infection – CDC Fact Sheet. Centers for Disease Control and Prevention, Atlanta
Chafe W, Richards A, Morgan L, Wilkinson E (1988) Unrecognized invasive carcinoma in vulvar intraepithelial neoplasia (VIN). Gynecol Oncol 31:154–165
Chen H, Gonzalez JL, Brennick JB et al (2010) Immunohistochemical patterns of ProEx C in vulvar squamous lesions: detection of overexpression of MCM2 and TOP2A. Am J Surg Pathol 34:1250–1257
Chiesa-Vottero A, Dvoretsky PM, Hart WR (2006) Histopathologic study of thin vulvar squamous cell carcinomas and associated cutaneous lesions: a correlative study of 48 tumors in 44 patients with analysis of adjacent vulvar intraepithelial neoplasia types and lichen sclerosus. Am J Surg Pathol 30:310–318
Clifford GM, Gallus S, Herrero R et al (2005) Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 366:991–998
Crowther ME, Lowe DG, Shepherd JH (1988) Verrucous carcinoma of the female genital tract: a review. Obstet Gynecol Surv 43:263–280
Crum CP, Haefner HK (2006) Epithelial and mixed epithelial-stromal neoplasms of the vagina. In: Crum CP, Lee KR (Hrsg) Diagnostic gynecologic and obstetric pathology. Elsevier, Philadelphia, S 245–266
Daling JR, Madeleine MM, Schwartz SM et al (2002) A population-based study of squamous cell vaginal cancer: HPV and cofactors. Gynecol Oncol 84:263–270
Datta SD, Koutsky LA, Ratelle S et al (2008) Human papillomavirus infection and cervical cytology in women screened for cervical cancer in the United States, 2003–2005. Ann Intern Med 148:493–500
Koning MN de, Quint WG, Pirog EC (2008) Prevalence of mucosal and cutaneous human papillomaviruses in different histologic subtypes of vulvar carcinoma. Mod Pathol 21:334–344
Sanjosé S de, Diaz M, Castellsagué X et al (2007) Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 7:453–459
Diakomanolis E, Stefanidis K, Rodolakis A et al (2002) Vaginal intraepithelial neoplasia: report of 102 cases. Eur J Gynaecol Oncol 23:457–459
Ferenczy A, Mitao M, Nagai N et al (1985) Latent papillomavirus and recurring genital warts. N Engl J Med 313:784–788
Fox H, Wells M (2003) Recent advances in the pathology of the vulva. Histopathology 42:209–216
Fuste V, Pino M del, Perez A et al (2010) Primary squamous cell carcinoma of the vagina: human papillomavirus detection, p16(INK4 A) overexpression and clinicopathological correlations. Histopathology 57:907–916
Gao Z, Bhuiya T, Falkowski O (2005) Papillary squamotransitional cell carcinoma of the vagina: a case report and review of literature. J Obstet Gynaecol 25:94–96
Gissmann L, deVilliers EM, zur Hausen H (1982) Analysis of human genital warts (condylomata acuminata) and other genital tumors for human papillomavirus type 6 DNA. Int J Cancer 29:143–146
Goffin F, Mayrand MH, Gauthier P et al (2006) High-risk human papillomavirus infection of the genital tract of women with a previous history or current high-grade vulvar intraepithelial neoplasia. J Med Virol 78:814–819
Gualco M, Bonin S, Foglia G et al (2003) Morphologic and biologic studies on ten cases of verrucous carcinoma of the vulva supporting the theory of a discrete clinico-pathologic entity. Int J Gynecol Cancer 13:317–324
Guerrero D, Guarch R, Ojer A et al (2011) Differential hypermethylation of genes in vulvar cancer and lichen sclerosus coexisting or not with vulvar cancer. Int J Cancer 128:2835–2864
Haidopoulos D, Diakomanolis E, Rodolakis A et al (2005) Coexistence of verrucous and squamous carcinoma of the vulva. Aust N Z J Obstet Gynaecol 45:60–63
Hampl M, Sarajuuri H, Wentzensen N et al (2006) Effect of human papillomavirus vaccines on vulvar, vaginal, and anal intraepithelial lesions and vulvar cancer. Obstet Gynecol 108:1361–1368
Hampl M, Wentzensen N, Vinokurova S et al (2007) Comprehensive analysis of 130 multicentric intraepithelial female lower genital tract lesions by HPV typing and p16 expression profile. J Cancer Res Clin Oncol 133:235–245
Hampl M, Huppertz E, Schulz-Holstege O et al (2011) Economic burden of vulvar and vaginal intraepithelial neoplasia: retrospective cost study at a German dysplasia centre. BMC Infect Dis 11:73
Hantschmann P, Sterzer S, Jeschke U, Friese K (2005) P53 expression in vulvar carcinoma, vulvar intraepithelial neoplasia, squamous cell hyperplasia and lichen sclerosus. Anticancer Res 25:1739–1745
Hart WR (2001) Vulvar intraepithelial neoplasia: historical aspects and current status. Int J Gynecol Pathol 20:16–30
Heller DS (2007) Report of a new ISSVD classification of VIN. J Low Genit Tract Dis 11:46–47
Hellman K, Lundell M, Silfverswärd C et al (2006) Clinical and histopathologic factors related to prognosis in primary squamous cell carcinoma of the vagina. Int J Gynecol Cancer 16:1201–1211
Hoevenaars BM, Avoort IA van der, Wilde PC de et al (2008) A panel of p16(INK4 A), MIB1 and p53 proteins can distinguish between the 2 pathways leading to vulvar squamous cell carcinoma. Int J Cancer 123:2767–2773
Horn LC, Schierle K (2009) Pathologie der Präkanzerosen und der Karzinome von Vulva und Vagina sowie morphologische Prognosefaktoren. Onkologe 15:15–27
Horn LC, Klostermann K, Schnürch HG, Hantschmann P (2009) Präkanzerosen der Vulva: Klassifikation und molekulare Pathogenese. Geburtshilfe Frauenheilkd 69:101–107
Insinga RP, Liaw KL, Johnson LG, Madeleine MM (2008) A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal, and vulvar precancers and cancers in the United States. Cancer Epidemiol Biomarkers Prev 17:1611–1622
Jones RW (1995) The natural history of vulvar intraepithelial neoplasia. Br J Obstet Gynaecol 102:764–766
Kagie MJ, Kenter GG, Tollenaar RA et al (1997) p53 protein overexpression, a frequent observation in squamous cell carcinoma of the vulva and in various synchronous vulvar epithelia, has no value as a prognostic parameter. Int J Gynecol Pathol 16:124–130
Kondi-Paphitis A, Deligeorgi-Politi H, Liapis A, Plemenou-Frangou M (1998) Human papilloma virus in verrucus carcinoma of the vulva: an immunopathological study of three cases. Eur J Gynaecol Oncol 19:319–320
Koutsky L (1997) Epidemiology of genital human papillomavirus infection. Am J Med 102:3–8
Kruse AJ, Bottenberg MJ, Tosserams J et al (2008) The absence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to the HPV-independent pathway as the causative agent for vulvar squamous cell carcinoma and its precursor simplex VIN in a young patient. Int J Gynecol Pathol 27:591–595
Kürzl R (2009) Nichtmaligne Hauterkrankungen der Vulva. Gynakologe 42:256–264
Kürzl R (2009) Praänivasive Erkrankungen der Vulva: Vulväre intraepitheliale Neoplasie (VIN) und M. Paget. Gynakologe 42:265–274
Kurman RJ, Toki T, Schiffman MH (1993) Basaloid and warty carcinomas of the vulva. Distinctive types of squamous cell carcinoma frequently associated with human papillomaviruses. Am J Surg Pathol 17:133–145. Erratum in: Am J Surg Pathol 17:536
Liegl B, Regauer S (2006) p53 immunostaining in lichen sclerosus is related to ischaemic stress and is not a marker of differentiated vulvar intraepithelial neoplasia (d-VIN). Histopathology 48:268–274
Logani S, Lu D, Quint WG et al (2003) Low-grade vulvar and vaginal intraepithelial neoplasia: correlation of histologic features with human papillomavirus DNA detection and MIB-1 immunostaining. Mod Pathol 16:735–741
McCluggage WG, Jamison J, Boyde A, Ganesan R (2009) Vulval intraepithelial neoplasia with mucinous differentiation: report of 2 cases of a hitherto undescribed phenomenon. Am J Surg Pathol 33:945–949
McLachlin CM, Kozakewich H, Craighill M et al (1994) Histologic correlates of vulvar human papillomavirus infection in children and young adults. Am J Surg Pathol 18:728–735
Medeiros F, Nascimento AF, Crum CP (2005) Early vulvar squamous neoplasia: advances in classification, diagnosis, and differential diagnosis. Adv Anat Pathol 12:20–26
Mulvany NJ, Allen DG (2008) Differentiated intraepithelial neoplasia of the vulva. Int J Gynecol Pathol 27:125–135
Murao K, Kubo Y, Ohtani N et al (2006) Epigenetic abnormalities in cutaneous squamous cell carcinomas: frequent inactivation of the RB1/p16 and p53 pathways. Br J Dermatol 155:999–1005
Nogueira MC, Guedes Neto Ede P, Rosa MW et al (2006) Immunohistochemical expression of p16 and p53 in vulvar intraepithelial neoplasia and squamous cell carcinoma of the vulva. Pathol Oncol Res 12:153–157
Okagaki T, Clark BA, Zachow KR et al (1984) Presence of human papillomavirus in verrucous carcinoma (Ackerman) of the vagina. Immunocytochemical, ultrastructural, and DNA hybridization studies. Arch Pathol Lab Med 108:567–570
O’Neill CJ, McCluggage WG (2006) p16 expression in the female genital tract and its value in diagnosis. Adv Anat Pathol 13:8–15
Ordi J, Alejo M, Fusté V et al (2009) HPV-negative vulvar intraepithelial neoplasia (VIN) with basaloid histologic pattern: an unrecognized variant of simplex (differentiated) VIN. Am J Surg Pathol 33:1659–1665
Pinto AP, Lin MC, Sheets EE et al (2000) Allelic imbalance in lichen sclerosus, hyperplasia, and intraepithelial neoplasia of the vulva. Gynecol Oncol 77:171–176
Polterauer S, Catharina Dressler A, Grimm C et al (2009) Accuracy of preoperative vulva biopsy and the outcome of surgery in vulvar intraepithelial neoplasia 2 and 3. Int J Gynecol Pathol 28:559–562
Preti M, Mezzetti M, Robertson C, Sideri M (2000) Inter-observer variation in histopathological diagnosis and grading of vulvar intraepithelial neoplasia: results of an European collaborative study. BJOG 107:594–599
Rastkar G, Okagaki T, Twiggs LB, Clark BA (1982) Early invasive and in situ warty carcinoma of the vulva: clinical, histologic, and electron microscopic study with particular reference to viral association. Am J Obstet Gynecol 143:814–820
Roma AA, Hart WR (2007) Progression of simplex (differentiated) vulvar intraepithelial neoplasia to invasive squamous cell carcinoma: a prospective case study confirming its precursor role in the pathogenesis of vulvar cancer. Int J Gynecol Pathol 26:248–253
Rufforny I, Wilkinson EJ, Liu C et al (2005) Human papillomavirus infection and p16(INK4a) protein expression in vulvar intraepithelial neoplasia and invasive squamous cell carcinoma. J Low Genit Tract Dis 9:108–113
Schiffman M, Castle PE (2003) Human papillomavirus: epidemiology and public health. Arch Pathol Lab Med 127:930–934
Scurry J, Wilkinson EJ (2006) Review of terminology of precursors of vulvar squamous cell carcinoma. J Low Genit Tract Dis 10:161–169
Shatz P, Bergeron C, Wilkinson EJ et al (1989) Vulvar intraepithelial neoplasia and skin appendage involvement. Obstet Gynecol 74:769–774
Sideri M, Jones RW, Wilkinson EJ et al (2005) Squamous vulvar intraepithelial neoplasia: 2004 modified terminology, ISSVD Vulvar Oncology Subcommittee. J Reprod Med 50:807–810
Smith JS, Backes DM, Hoots BE et al (2009) Human papillomavirus type-distribution in vulvar and vaginal cancers and their associated precursors. Obstet Gynecol 113:917–924
Srodon M, Stoler MH, Baber GB, Kurman RJ (2006) The distribution of low and high-risk HPV types in vulvar and vaginal intraepithelial neoplasia (VIN and VaIN). Am J Surg Pathol 30:1513–1518
Stanley M (2010) Pathology and epidemiology of HPV infection in females. Gynecol Oncol 117(2 Suppl):5–10
Sugase M, Matsukura T (1997) Distinct manifestations of human papillomaviruses in the vagina. Int J Cancer 72:412–415
Ueda Y, Enomoto T, Kimura T et al (2011) Two distinct pathways to development of squamous cell carcinoma of the vulva. J Skin Cancer 2011, doi:10.1155/2011/951250
Nieuwenhof HP van de, Bulten J, Hollema H et al (2011) Differentiated vulvar intraepithelial neoplasia is often found in lesions, previously diagnosed as lichen sclerosus, which have progressed to vulvar squamous cell carcinoma. Mod Pathol 24:297–305
Nieuwenhof HP van de, Avoort IA van der, Hullu JA de (2008) Review of squamous premalignant vulvar lesions. Crit Rev Oncol Hematol 68:131–156
Avoort IA van der, Shirango H, Hoevenaars BM et al (2006) Vulvar squamous cell carcinoma is a multifactorial disease following two separate and independent pathways. Int J Gynecol Pathol 25:22–29
Seters M van, Beurden M van, Craen AJ de (2005) Is the assumed natural history of vulvar intraepithelial neoplasia III based on enough evidence? A systematic review of 3322 published patients. Gynecol Oncol 97:645–651
Waggoner SE, Anderson SM, Van Eyck S et al (1994) Human papillomavirus detection and p53 expression in clear-cell adenocarcinoma of the vagina and cervix. Obstet Gynecol 84:404–408
Wilkinson EJ, Teixeira MR (2003) Tumors of the vulva. In: Tavassoli FA, Devilee P (Hrsg) Pathology and genetics of tumours of the breast and female genital organs. World Health Organization classification of tumours. IARC, Lyon, S 313–334
Winer RL, Lee SK, Hughes JP et al (2003) Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol 157:218–226. Erratum in: Am J Epidemiol 157:858
Yang B, Hart WR (2000) Vulvar intraepithelial neoplasia of the simplex (differentiated) type: a clinicopathologic study including analysis of HPV and p53 expression. Am J Surg Pathol 24:429–441
Zaloudek C, Rabban JT (2005) Differentiated vulva intraepithelial neoplasia (VIN): an underrecognised form of high grade VIN associated with keratinising squamous cell carcinoma of the vulva. Pathol Case Rev 10:35–40
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Additional information
L.-C. Horn und G. Mehlhorn sind Mitglieder in der Organkommission Vulva/Vagina der Arbeitsgemeinschaft Gynäkologische Onkologie (AGO).
Rights and permissions
About this article
Cite this article
Horn, LC., Klostermann, K., Hautmann, S. et al. HPV-assoziierte Veränderungen an Vulva und Vagina. Pathologe 32, 467–475 (2011). https://doi.org/10.1007/s00292-011-1476-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00292-011-1476-5